Source author record

S. Date

S. Date appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

4works
3topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2021arXiv

SPring-8 LEPS2 beamline: A facility to produce a multi-GeV photon beam via laser Compton scattering

We have constructed a new laser-Compton-scattering facility, called the LEPS2 beamline, at the 8-GeV electron storage ring, SPring-8. This facility provides a linearly polarized photon beam in a tagged energy range of 1.3--2.4 GeV. Thanks to a small divergence of the low-emittance storage-ring electrons, the tagged photon beam has a size (sigma) suppressed to about 4 mm even after it travels about 130 m to the experimental building that is independent of the storage ring building and contains large detector systems. This beamline is designed to achieve a photon beam intensity higher than that of the first laser-Compton-scattering beamline at SPring-8 by adopting the simultaneous injection of up to four high-power laser beams and increasing a transmittance for the long photon-beam path up to about 77%. The new beamline is under operation for hadron photoproduction experiments.

preprint2016arXiv

Interference effect between $ϕ$ and $Λ(1520)$ production channels in the $γp \rightarrow K^+K^-p$ reaction near threshold

The $ϕ$-$Λ(1520)$ interference effect in the $γp\to K^+K^-p$ reaction has been measured for the first time in the energy range from 1.673 to 2.173 GeV. The relative phases between $ϕ$ and $Λ(1520)$ production amplitudes were obtained in the kinematic region where the two resonances overlap. The measurement results support strong constructive interference when $K^+K^-$ pairs are observed at forward angles, but destructive interference for proton emission at forward angles. Furthermore, the observed interference effect does not account for the $\sqrt{s}=2.1$ GeV bump structure in forward differential cross sections for $ϕ$ photoproduction. This fact suggests possible exotic structures such as a hidden-strangeness pentaquark state, a new Pomeron exchange and rescattering processes via other hyperon states.

preprint2013arXiv

Backward-angle photoproduction of $ω$ and $η'$ mesons from protons at $E_γ=1.5-3.0$ GeV

We report the measurement of differential cross sections for $ω$ and $η'$ photoproduction from protons at backward angles ($-1.0<\cosΘ_{C.M}^{X}<-0.8$) using linearly polarized photons at $E_γ=$$1.5-3.0$ GeV. Differential cross sections for $ω$ mesons are larger than the predicted $u$-channel contribution in the energy range $2.0\leq\sqrt{s}\leq2.4$ GeV. The differential cross sections for $ω$ and $η'$ mesons become closer to the predicted $u$-channel contribution at $\sqrt{s}>2.4$ GeV. A bump structure in the $\sqrt{s}$ dependence of the differential cross sections for $η'$ mesons was observed at $\sqrt{s}\sim$2.35 GeV.

preprint2011arXiv

Coherent photonuclear reactions for isotope transmutation

Coherent photonuclear isotope transmutation (CPIT) produces exclusively radioactive isotopes (RIs) by coherent photonuclear reactions via E1 giant resonances. Photons to be used are medium energy photons produced by laser photons backscattered off GeV electrons. The cross sections are as large as 0.2 - 0.6 b, being independent of individual nuclides. A large fraction of photons is effectively used for the photonuclear reactions, while the scattered GeV electrons remain in the storage ring to be re-used. CPIT with medium energy photons provides specific/desired RIs with the high rate and the high density for nuclear science, molecular biology and for nuclear medicines.